Arkolith/Insider Trading/RAPP/Form 4

Bredt David

Chief Scientific OfficerRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Jan 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$228K
Net Open-Market Flow
-$228K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 15, 2026Sell(S)8K$26.83$223K396K
Jan 15, 2026Sell(S)200$27.40$5K396K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-015350) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML